Ultrabol 150

ULTRABOL 150 BY BRITISH DRAGON PHARMACEUTICALS

Injectable Oily Solution

DRUG COMPOSITION

1 mL of solution contains:
- active substance: drost p, test p, tren a 150 mg;
- auxiliary substances:

DRUG DESCRIPTION

Transparent oily solution, from yellow to light yellow color, with characteristic smell.

PHARMACEUTICAL FORM

Injectable oily solution.

PHARMACEUTICAL GROUP AND ATC CODE

Injectable Anabolic Steroid.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: 2-3 Days
Routes of administration: intramuscular injection
Dosage forms: (Men): 500-750 mg/week; (Women): -
Acne: yes
Water retention: no
High blood pressure: perhaps
Hepatotoxicity: yes
Aromatase: yes
Decreased HPTA function (own testosterone production): -
Anabolic activity: -
Androgenic activity: -
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

Injectable oily solution 150 mg / 1 mL in 10 mL Vial vials.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

March 2020

NAME AND ADDRESS OF THE MANUFACTURER

British Dragon Pharmaceuticals
Europe